BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33813517)

  • 1. Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism.
    Liu Y; Ren XY; Peng YG; Chen SK; Cheng XR; Qin M; Wang XL; Song YN; Fan LJ; Gong CX
    Chin Med J (Engl); 2021 Mar; 134(10):1152-1159. PubMed ID: 33813517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
    Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
    Lin J; Mao J; Wang X; Ma W; Hao M; Wu X
    Medicine (Baltimore); 2019 Aug; 98(31):e16616. PubMed ID: 31374027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
    Huang Z; Wang X; Yu B; Ma W; Zhang P; Wu X; Nie M; Mao J
    Arch Endocrinol Metab; 2024 May; 68():e230101. PubMed ID: 38739523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations Among Genotype and Outcome in Chinese Male Patients With Congenital Hypogonadotropic Hypogonadism Under HCG Treatment.
    Chen Y; Sun T; Niu Y; Wang D; Xiong Z; Li C; Liu K; Qiu Y; Sun Y; Gong J; Wang T; Wang S; Xu H; Liu J
    J Sex Med; 2020 Apr; 17(4):645-657. PubMed ID: 32171629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism].
    Huang B; Mao J; Xu H; Wang X; Liu Z; Nie M; Wu X
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(20):1568-71. PubMed ID: 26463603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
    Büchter D; Behre HM; Kliesch S; Nieschlag E
    Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism.
    Kirk JM; Savage MO; Grant DB; Bouloux PM; Besser GM
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):57-63. PubMed ID: 7914153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism.
    Liu L; Chaudhari N; Corle D; Sherins RJ
    Fertil Steril; 1988 Feb; 49(2):302-8. PubMed ID: 3123278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsatile Gonadotropin-Releasing Hormone Therapy Is Associated With Better Spermatogenic Outcomes than Gonadotropin Therapy in Patients With Pituitary Stalk Interruption Syndrome.
    Zhang J; Zhu Y; Zhang R; Liu H; Sun B; Zhang W; Wang X; Nie M; Mao J; Wu X
    Endocr Pract; 2024 Feb; 30(2):146-154. PubMed ID: 38029930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
    Ley SB; Leonard JM
    J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
    Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
    Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients.
    Liu Z; Mao J; Wu X; Xu H; Wang X; Huang B; Zheng J; Nie M; Zhang H
    Medicine (Baltimore); 2016 Mar; 95(9):e2867. PubMed ID: 26945370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men.
    Zhang L; Cai K; Wang Y; Ji W; Cheng Z; Chen G; Liao Z
    Am J Mens Health; 2019; 13(1):1557988318818280. PubMed ID: 30569789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients.
    Hao M; Nie M; Yu BQ; Gao YJ; Wang X; Ma WL; Huang QB; Zhang R; Mao JF; Wu XY
    Asian J Androl; 2020; 22(4):390-395. PubMed ID: 31464203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testicular findings, endocrine features and therapeutic responses of men with idiopathic hypogonadotropic hypogonadism].
    Tachiki H; Kumamoto Y; Itoh N; Maruta H; Tsukamoto T
    Nihon Naibunpi Gakkai Zasshi; 1995 May; 71(4):605-22. PubMed ID: 7796925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
    Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
    Yang L; Zhang SX; Dong Q; Xiong ZB; Li X
    Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism.
    Boeri L; Capogrosso P; Salonia A
    Curr Pharm Des; 2021; 27(24):2775-2783. PubMed ID: 32445446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.